Research has revealed elevated FOXO1 expression in DOX-resistant triple-negative breast cancer (TNBC) cells, where it maintains redox homeostasis in chemotherapy-resistant cells (22). This evidence concerns the gene FOXO1 and triple-negative breast carcinoma.